Drugs / Ad5CMV-NIS
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00788307 | Nov 2008 → Feb 2018 | prostate cancer | Mayo Clinic | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ad5CMV-NIS | “Placing a gene called Ad5CMV-NIS in prostate cancer cells may help the prostate cells take in more radioactive iodine and thus kill the cancer cells.” NCT00788307 ↗ |
| Route | Other | “receive intraprostate Ad5CMV-NIS, via transperineal injection under anesthesia” NCT00788307 ↗ |